Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Elena Ioana Braicu, Silvia Darb-Esfahani, Wolfgang D. Schmitt, Kaisa M. Koistinen, Laura Heiskanen, Päivi Pöhö, Jan Budczies, Marc Kuhberg, Manfred Dietel, Christian Frezza, Carsten Denkert, Jalid Sehouli, Mika Hilvo
Published Oct 26, 2017 · Vol. 8, No. 61 · pp. 102912-102922
Inna Chen, Victoria M. Raymond, Jennifer A. Geis, Eric A. Collisson, Benny V. Jensen, Kirstine L. Hermann, Mark G. Erlander, Margaret Tempero, Julia S. Johansen
Published Oct 26, 2017 · Vol. 8, No. 58 · pp. 97769-97786
Fiebo J.C. Ten, Lucia Suzuki, Lambert C.J. Dorssers, Winand N.M. Dinjens, David T.W. Jones, Daan Nieboer, Michael Doukas, J. Jan B. Van Lanschot, Bas P.L. Wijnhoven, Leendert H.J. Looijenga, Katharina Biermann
Published Oct 24, 2017 · Vol. 8, No. 61 · pp. 104123-104135